Single fibre EMG in juvenile myasthenia gravis.
D000200:Action Potentials; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004491:Edrophonium / Q000627:therapeutic use; D004576:Electromyography; D005260:Female; D006801:Humans; D008297:Male; D009132:Muscles / Q000503:physiopathology*; D009157:Myasthenia Gravis / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology* / Q000628:therapy; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D000644:Quaternary Ammonium Compounds / Q000627:therapeutic use; D009435:Synaptic Transmission
D002800:Cholinesterase Inhibitors; D000644:Quaternary Ammonium Compounds; D004491:Edrophonium; D011729:Pyridostigmine Bromide